×
验证码:
换一张
Forgotten Password?
Stay signed in
Login With UMPASS
English
|
繁體
Login With UMPASS
Log In
ALL
ORCID
TI
AU
PY
SU
KW
TY
JN
DA
IN
PB
FP
ST
SM
Study Hall
Image search
Paste the image URL
Home
Faculties & Institutes
Scholars
Publications
Subjects
Statistics
News
Search in the results
Faculties & Institutes
Faculty of Healt... [3]
Institute of Chi... [2]
THE STATE KEY LA... [2]
Authors
KWOK HANG FAI [1]
BIAN YING [1]
LU JINJIAN [1]
Document Type
Journal article [3]
Review article [2]
Date Issued
2022 [1]
2021 [1]
2019 [1]
2017 [2]
Language
英語English [5]
Source Publication
Trends in Cancer [2]
CURRENT DRUG TAR... [1]
Current Topics i... [1]
Frontiers in Pha... [1]
Indexed By
SCIE [3]
Funding Organization
Funding Project
×
Knowledge Map
UM
Start a Submission
Submissions
Unclaimed
Claimed
Attach Fulltext
Bookmarks
Browse/Search Results:
1-5 of 5
Help
Selected(
0
)
Clear
Items/Page:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
Sort:
Select
Issue Date Ascending
Issue Date Descending
Journal Impact Factor Ascending
Journal Impact Factor Descending
WOS Cited Times Ascending
WOS Cited Times Descending
Submit date Ascending
Submit date Descending
Title Ascending
Title Descending
Author Ascending
Author Descending
Efficacy, safety, and cost-effectiveness analysis of aflibercept in metastatic colorectal cancer: A rapid health technology assessment
Review article
2022
Authors:
Ge, Pu
;
Wan, Ning
;
Han, Xiao
;
Wang, Xinpei
;
Zhang, Jinzi
; et al.
Favorite
|
TC[WOS]:
2
TC[Scopus]:
1
IF:
4.4
/
5.0
|
Submit date:2023/01/30
Aflibercept
Cost-effectiveness Analysis
Metastatic Colorectal Cancer
Pharmacoeconomics
Rapid Health Technology Assessment
Targeted Drugs
Review and prospect of tissue-agnostic targeted strategies in anticancer therapies
Review article
2021
Authors:
Yu Peng
;
Hongxun Tao
;
Yuanqing Gao
;
Yuanyuan Yang
;
Zhiyong Chen
Favorite
|
TC[WOS]:
6
TC[Scopus]:
5
IF:
2.9
/
3.1
|
Submit date:2022/05/13
Anticancer Therapy
Broad-spectrum Anticancer Targeted Drugs
Cancers
Chemotherapy
Precision Medicine
Tissue-agnostic Targeted Therapy
Investigational hypoxia-activated prodrugs: Making sense of future development
Journal article
Min Xia Su, Le Le Zhang, Zhang Jian Huang, Jia Jie Shi, Jin Jian Lu. Investigational hypoxia-activated prodrugs: Making sense of future development[J]. CURRENT DRUG TARGETS, 2019, 20(6), 668-678.
Authors:
Min Xia Su
;
Le Le Zhang
;
Zhang Jian Huang
;
Jia Jie Shi
;
Jin Jian Lu
Favorite
|
TC[WOS]:
9
TC[Scopus]:
11
IF:
3.0
/
3.3
|
Submit date:2021/03/02
Dna Alkylating Agents
Hypoxia-activated Prodrug
Patient Selection
Reductase Activity
Targeted Drugs
Topoisomerase Ii Inhibitors
Venom Peptides: Improving Specificity in Cancer Therapy
Journal article
Mahadevappa, Ravikiran, Ma, Rui, Kwok, Hang Fai. Venom Peptides: Improving Specificity in Cancer Therapy[J]. Trends in Cancer, 2017, 3(9), 611-614.
Authors:
Mahadevappa, Ravikiran
;
Ma, Rui
;
Kwok, Hang Fai
Favorite
|
TC[WOS]:
31
TC[Scopus]:
33
|
Submit date:2022/08/01
Combinatorial Anticancer Drugs
Immunotherapy
Targeted Cancer Therapy
Venom Peptides
Venom peptides -- Improving specificity for cancer therapy
Journal article
Mahadevappa, R., Ma, R., Kwok, H. F.. Venom peptides -- Improving specificity for cancer therapy[J]. Trends in Cancer, 2017, 611-614.
Authors:
Mahadevappa, R.
;
Ma, R.
;
Kwok, H. F.
Favorite
|
|
Submit date:2022/06/02
Venom Peptides
Targeted Cancer Therapy
Immunotherapy
Combinatorial Anticancer Drugs